This article provides a comprehensive narrative review of the history of antiepileptic drugs (AEDs) and their development over time. Firstly, it explores the significant role of serendipity in the discovery of essential AEDs that continue to be used today, such as phenobarbital and valproic acid. Subsequently, it delves into the historical progression of crucial preclinical models employed in the development of novel AEDs, including the maximal electroshock stimulation test, pentylenetetrazol-induced test, kindling models, and other animal models. Moving forward, a concise overview of the clinical advancement of major AEDs is provided, highlighting the initial milestones and the subsequent refinement of this process in recent decades, in line with the emergence of evidence-based medicine and the implementation of increasingly rigorous controlled clinical trials. Lastly, the article explores the contributions of artificial intelligence, while also offering recommendations and discussing future perspectives for the development of new AEDs.
Because of technical difficulties to access the autonomic function at the ACN due to multiple structures and widespread connections involved, approaches based on response measurements in the effector systems or organs are usually used7. The analysis of heart rate variability (HRV) is a noninvasive approach to the autonomic function that requires only an electrocardiographic record. With HRV it is possible to analyze in the time and frequency domains parameters associated with parasympathetic or sympathetic activity and its variations in different conditions. Changes in autonomic activity in stroke patients are well described in the acute phase related to cardiac and infectious complications that are the leading causes of non-neurological death8,9. Furthermore, it seems that the autonomic impairment persists during the chronic phase of stroke, impacting the prognosis of patients. Therefore, there is a growing interest in HRV analysis as a potential tool for prognosis and understanding of underlying mechanisms in post-stroke autonomic dysfunction.
The cardiovascular system exhibits circadian rhythmicity, responding to central and peripheral clocks. Sexual dimorphism and aging independently influence circadian rhythms and cardiac electrical activity, which the autonomic nervous system regulates. However, the extent to which sex and aging affect autonomic dynamics remains unclear. This study investigates their role in circadian cardiac autonomic activity in healthy subjects. Data from 51 males and 51 females with 24-hour Holter recordings were analyzed. Circadian patterns of Heart Rate Variability parameters, indicators of autonomic function, were assessed using fast Fourier transformation with 5-minute Blackman-Harris windows on artifact-free recordings. Fractal, multifractal, visual, and information methods were applied to evaluate parasympathetic and sympathetic influences. We calculated the means and standard deviation for all numeric variables. We found temporal fluctuations across the time domain and frequency parameters. Six of the eight nonlinear HRV parameters significantly fluctuated. Among the 17 fluctuating parameters analyzed, nine circadian indicators (MESOR, amplitude, and acrophase) showed significant differences between sexes, with women exhibiting higher vagal oscillatory activity. Aging diminished fluctuations across all parameters and was associated with chronodisruption of cardiac autonomic markers. These findings highlight neurohumoral differences as key modulators of cardiac autonomic dynamics. The interaction effect of sex and age impacts the circadian rhythmicity of cardiac electric activity, as reflected by the HRV analysis. Our results have implications for personalized diagnostics, treatment timing, risk prediction, and biomarkers, highlighting the need for age-and sex-specific approaches in precision medicine and chronomedicine.
Background Alterations of the autonomic nervous system (ANS) in the chronic stage of ischemic stroke (IS) are not well understood. Heart rate variability (HRV) provides a noninvasive approach to assess autonomic function. Objective To compare the HRV parameters during the sleep-wake cycle between patients with IS in the chronic stage and healthy subjects. Methods We conducted a retrospective transversal study based on clinical records and 24-hour electrocardiogram (EKG) monitoring registries of 179 patients with a confirmed IS diagnosis and 184 age- and sex-matched healthy subjects. Circadian variation was calculated according to the variation of the total autonomic activity (VTAI) and the parasympathetic activity (VPAI) indexes. Comparisons were performed using nonparametric tests. Multivariable analyses were performed with canonical discriminant analysis (CDA) and a three-way analysis of variance (ANOVA). Statistical significance was established with a confidence level of 95%. Results During waking hours, the healthy group exhibited higher variability in the time domain and frequency domain parameters: standard deviation of NN intervals (SDNN, p < 0.001) and of the average NN intervals (SDANN, p < 0.001), as well as low-frequency (LF) band (p < 0.001). During sleep, the difference was higher in the high-frequency (HF) band (p < 0.001), and lower in the low-/high-frequency ratio (LF/HF, p < 0.001). Both VPAI and VTAI showed less significant difference in IS patients (p < 0.001). Conclusion There was diminished heart vagal activity among IS patients, as measured through HRV. During sleep, this is likely caused by an imbalance in the sympathetic and parasympathetic systems shifting through the sleep phases. These imbalances could persist over time in patients with IS, lasting months after the initial injury.
Background: Heart failure (HF) is a complex clinical syndrome that presents significant challenges in diagnosis and treatment. Exploring innovative pathways to better understand the physiopathological mechanisms has led to the concept of cardiac remodeling (CR), which helps elucidate the diversity in clinical manifestations and treatment responses. However, the extent to which CR influences autonomic cardiac dynamics across the circadian cycle remains unclear. Methods: Recordings of 24 h ECG recordings from 86 Control subjects and 86 patients meeting the criteria for cardiac remodeling were analyzed. Heart rate variability (HRV) parameters were estimated using 5 min Blackman–Harris windows per hour. Autonomic influences on cardiac electrical activity were assessed using time-domain, frequency-domain, and nonlinear methods. Circadian parameters (MESOR, amplitude, and acrophase) were derived via Cosinor modeling, and group differences were evaluated while controlling for age, sex, and medication effects. Results: Patients with CR exhibited reduced oscillatory activity in HRV measures compared with Control. MESOR and amplitude were significantly lower in CR patients, who also displayed an advanced-phase phenotype across multiple HRV domains over 24 h. Additionally, CR patients showed decreased complexity and entropy in nonlinear dynamics. Conclusions: Altered circadian rhythmicity of cardiac electrical activity is evidenced in cardiac remodeling by changes in circadian HRV parameters and nonlinear dynamics.
To perform autonomic cardiovascular tests on patients with suspected OSA. In 2020, patients aged ≥18 years without difficult-to-control hypertension, cardiopathy, or pulmonary disease executed 6Hz deep breathing, 15-second Valsalva maneuver (40mmHg), and 5-minute active standing after the type 1 polysomnography at the Neurology (Federal University of São Paulo). The tests recorded blood pressure using beat-to-beat plethysmography, an electrocardiogram, and respiratory effort. Among the seventeen patients, ten had moderate OSA, and twelve were male. The mean age and disease duration were 52 and 14 years. Hypertension and obesity were frequent. They had mild autonomic symptom burden, mainly adrenergic sympathetic overactivity, and at least one-third of them had cardiovagal abnormalities. A small sample of patients with untreated moderate-to-severe OSA had autonomic abnormalities in tests using beat-to-beat blood pressure. Sympathetic overdrive in long-term daytime was manifested as orthostatic hypertension. Emerging technologies contributed to diagnosing the OSA-related autonomic dysfunction beyond the polysomnographic approach.